{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:27Z","timestamp":1791389187295,"version":"4.3.3"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11886-018-1030-7","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T08:32:22Z","timestamp":1534149142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Genetics of Dilated Cardiomyopathy: Clinical Implications"],"prefix":"10.1007","volume":"20","author":[{"given":"A.","family":"Paldino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dal Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mestroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ppedcard.2014.10.003","volume":"37","author":"L Mestroni","year":"2014","unstructured":"Mestroni L, Brun F, Spezzacatene A, Sinagra G, Taylor MR. Genetic causes of dilated cardiomyopathy. Prog Pediatr Cardiol. 2014;37:13\u20138.","journal-title":"Prog Pediatr Cardiol"},{"key":"1030_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1161\/CIRCULATIONAHA.116.024258","volume":"135","author":"VN Parikh","year":"2017","unstructured":"Parikh VN, Ashley EA. Next-generation sequencing in cardiovascular disease: present clinical applications and the horizon of precision medicine. Circulation. 2017;135:406\u20139.","journal-title":"Circulation"},{"key":"1030_CR3","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1136\/heartjnl-2015-308190","volume":"102","author":"V Favalli","year":"2016","unstructured":"Favalli V, Serio A, Grasso M, Arbustini E. Genetic causes of dilated cardiomyopathy. Heart. 2016;102:2004\u201314.","journal-title":"Heart"},{"key":"1030_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","volume":"36","author":"J Haas","year":"2015","unstructured":"\u2022\u2022 Haas J, Frese KS, Peil B, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J. 2015;36:1123\u201335. This article is the most comprehensive study on the distribution of genes, the number of mutations and mutational burden of patients with DCM.","journal-title":"Eur Heart J"},{"key":"1030_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HCO.0b013e32835fb728","volume":"28","author":"AC Sturm","year":"2013","unstructured":"Sturm AC, Hershberger RE. Genetic testing in cardiovascular medicine: current landscape and future horizons. Curr Opin Cardiol. 2013;28:317\u201325.","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"1030_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-017-0410-8","volume":"9","author":"U Tayal","year":"2017","unstructured":"Tayal U, Prasad S, Cook SA. Genetics and genomics of dilated cardiomyopathy and systolic heart failure. Genome Med. 2017;9(1):20. https:\/\/doi.org\/10.1186\/s13073-017-0410-8 .","journal-title":"Genome Med"},{"key":"1030_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19:192\u2013203.","journal-title":"Genet Med"},{"key":"1030_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mgg3.245","volume":"4","author":"N Nouhravesh","year":"2016","unstructured":"Nouhravesh N, Ahlberg G, Ghouse J, Andreasen C, Svendsen JH, Hauns\u00f8 S, et al. Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy. Mol Genet Genomic Med. 2016;4:617\u201323.","journal-title":"Mol Genet Genomic Med"},{"key":"1030_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"1030_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Quan Li","year":"2017","unstructured":"Li Q, Wang K, McPherson JD, et al. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet 2017:100:267\u2013280. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.004 .","journal-title":"The American Journal of Human Genetics"},{"key":"1030_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI62862","volume":"123","author":"EM McNally","year":"2013","unstructured":"McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 2013;123:19\u201326.","journal-title":"J Clin Invest"},{"key":"1030_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121:731\u201348.","journal-title":"Circ Res"},{"key":"1030_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCGENETICS.109.912345","volume":"3","author":"RE Hershberger","year":"2010","unstructured":"Hershberger RE, Norton N, Morales A, Li D, Siegfried JD, Gonzalez-Quintana J. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet. 2010;3:155\u201361.","journal-title":"Circ Cardiovasc Genet"},{"key":"1030_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cardfail.2006.03.009","volume":"12","author":"JD Kushner","year":"2006","unstructured":"Kushner JD, Nauman D, Burgess D, Ludwigsen S, Parks SB, Pantely G, et al. Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy. J Card Fail. 2006;12:422\u20139.","journal-title":"J Card Fail"},{"key":"1030_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s10897-012-9532-8","volume":"22","author":"JD Siegfried","year":"2013","unstructured":"Siegfried JD, Morales A, Kushner JD, Burkett E, Cowan J, Mauro AC, et al. Return of genetic results in the familial dilated cardiomyopathy research project. J Genet Couns. 2013;22:164\u201374.","journal-title":"J Genet Couns"},{"key":"1030_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10:531\u201347.","journal-title":"Nat Rev Cardiol"},{"key":"1030_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman DS, Lam L, Taylor MRG, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619\u201328.","journal-title":"N Engl J Med"},{"issue":"12","key":"1030_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145284","volume":"10","author":"O Akinrinade","year":"2015","unstructured":"Akinrinade O, Koskenvuo JW, Alastalo TP. Prevalence of titin truncating variants in general population. PLoS One. 2015;10(12):e0145284. https:\/\/doi.org\/10.1371\/journal.pone.0145284 .","journal-title":"PLoS One"},{"issue":"23","key":"1030_CR19","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","volume":"343","author":"M Kamisago","year":"2000","unstructured":"Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343(23):1688\u201396. https:\/\/doi.org\/10.1056\/NEJM200012073432304 .","journal-title":"N Engl J Med"},{"key":"1030_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/gim.2013.204","volume":"16","author":"TJ Pugh","year":"2014","unstructured":"Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014;16:601\u20138.","journal-title":"Genet Med"},{"key":"1030_CR21","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/heartjnl-2016-311017","volume":"103","author":"M Dal Ferro","year":"2017","unstructured":"\u2022 Dal Ferro M, Stolfo D, Altinier A, et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart. 2017;103:1704\u201310. This study provides the important evidence that the response to therapy in terms of LVRR could be influenced by the mutational status (especially, cytoskeleton Z-disk rare variants are associater with lower rate of reverse remodeling).","journal-title":"Heart"},{"key":"1030_CR22","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","volume":"4","author":"RL Begay","year":"2018","unstructured":"Begay RL, Graw SL, Sinagra G, Asimaki A, Rowland TJ, Slavov DB, et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell\u2013cell adhesion structures. JACC Clin Electrophysiol. 2018;4:504\u201314.","journal-title":"JACC Clin Electrophysiol"},{"key":"1030_CR23","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","volume":"68","author":"MF Ortiz-Genga","year":"2016","unstructured":"\u2022 Ortiz-Genga MF, Cuenca S, Dal Ferro M, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol. 2016;68:2440\u201351. This article is important because it provides the evidence of an arrhythmogenic phenotype caused by FLNC mutations in a relatively large cohort of patients.","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR24","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.106.646778","volume":"115","author":"MRG Taylor","year":"2007","unstructured":"Taylor MRG, Slavov D, Ku L, di Lenarda A, Sinagra G, Carniel E, et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation. 2007;115:1244\u201351.","journal-title":"Circulation"},{"key":"1030_CR25","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","volume":"275","author":"L Politano","year":"1996","unstructured":"Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. J Am Med Assoc. 1996;275:1335\u20138.","journal-title":"J Am Med Assoc"},{"key":"1030_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","volume":"41","author":"MRG Taylor","year":"2003","unstructured":"Taylor MRG, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, et al. Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations. J Am Coll Cardiol. 2003;41:771\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCGENETICS.110.937805","volume":"3","author":"P Elliott","year":"2010","unstructured":"Elliott P, O\u2019Mahony C, Syrris P, Evans A, Sorensen CR, Sheppard MN, et al. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ Cardiovasc Genet. 2010;3:314\u201322.","journal-title":"Circ Cardiovasc Genet"},{"key":"1030_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1399-0004.2008.01062.x","volume":"74","author":"SC Menon","year":"2008","unstructured":"Menon SC, Michels VV, Pellikka PA, Ballew JD, Karst ML, Herron KJ, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet. 2008;74:445\u201354.","journal-title":"Clin Genet"},{"key":"1030_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ejhg.2013.16","volume":"21","author":"R Roncarati","year":"2013","unstructured":"Roncarati R, Viviani Anselmi C, Krawitz P, Lattanzi G, von Kodolitsch Y, Perrot A, et al. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet. 2013;21:1105\u201311.","journal-title":"Eur J Hum Genet"},{"key":"1030_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/ejhg.2014.211","volume":"23","author":"MW Wessels","year":"2015","unstructured":"Wessels MW, Herkert JC, Frohn-Mulder IM, Dalinghaus M, Van Den Wijngaard A, De Krijger RR, et al. Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects. Eur J Hum Genet. 2015;23:922\u20138.","journal-title":"Eur J Hum Genet"},{"key":"1030_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1138","volume":"20","author":"S Frantz","year":"2018","unstructured":"Frantz S, Falcao-Pires I, Balligand JL, Bauersachs J, Brutsaert D, Ciccarelli M, et al. The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC. Eur J Heart Fail. 2018;20:445\u201359.","journal-title":"Eur J Heart Fail"},{"key":"1030_CR32","doi-asserted-by":"crossref","unstructured":"Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374:233\u201341.","DOI":"10.1056\/NEJMoa1505517"},{"key":"1030_CR33","first-page":"455","volume":"13","author":"PM Deshmukh","year":"2004","unstructured":"Deshmukh PM, Krishnamani R, Romanyshyn M, Johnson AK, Noti JD. Association of angiotensin converting enzyme gene polymorphism with tachycardia cardiomyopathy. Int J Mol Med. 2004;13:455\u20138.","journal-title":"Int J Mol Med"},{"key":"1030_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.4330\/wjc.v6.i8.771","volume":"6","author":"G Guzzo-merello","year":"2014","unstructured":"Guzzo-merello G, Cobo-marcos M, Gallego-delgado M, Garcia-pavia P, Guzzo-merello G, Cobo-marcos M, et al. Alcoholic cardiomyopathy. World J Cardiol. 2014;6:771\u201381.","journal-title":"World J Cardiol"},{"issue":"1","key":"1030_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000116","volume":"1","author":"M Wasielewski","year":"2014","unstructured":"Wasielewski M, Van Spaendonck-Zwarts KY, Westerink NDL, Jongbloed JDH, Postma A, Gietema JA, et al. Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy. Open Hear. 2014;1(1):e000116. https:\/\/doi.org\/10.1136\/openhrt-2014-000116 .","journal-title":"Open Hear"},{"issue":"20","key":"1030_CR36","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","volume":"71","author":"JS Ware","year":"2018","unstructured":"Ware JS, Amor-salamanca A, Tayal U, et al. Genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol. 2018;71(20):2293\u2013302. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.462 .","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12471-018-1079-3","volume":"26","author":"A Zorzi","year":"2018","unstructured":"Zorzi A, Pelliccia A, Corrado D. Inherited cardiomyopathies and sports participation. Netherlands Hear J. 2018;26:154\u201365.","journal-title":"Netherlands Hear J"},{"key":"1030_CR38","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.106.624502","volume":"114","author":"P Kirchhof","year":"2006","unstructured":"Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S, et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation. 2006;114:1799\u2013806.","journal-title":"Circulation"},{"key":"1030_CR39","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jacc.2015.07.023","volume":"66","author":"MR Hazebroek","year":"2015","unstructured":"Hazebroek MR, Moors S, Dennert R, van den Wijngaard A, Krapels I, Hoos M, et al. Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy applying the MOGE(S) classification. J Am Coll Cardiol. 2015;66:1313\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR40","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","volume":"31","author":"P Charron","year":"2010","unstructured":"Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31:2715\u201328.","journal-title":"Eur Heart J"},{"issue":"2","key":"1030_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1103","volume":"20","author":"M Merlo","year":"2018","unstructured":"\u2022 Merlo M, Cannat\u00e0 A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20(2):228\u201339. This review offers a comprehensive survey of emerging issues in the clinical management of DCM, providing where possible practical recommendations.","journal-title":"Eur J Heart Fail"},{"key":"1030_CR42","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016:37:2129\u20132200m.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"1030_CR43","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/europace\/eur245","volume":"13","author":"MJ Ackerman","year":"2011","unstructured":"Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace. 2011;13:1077\u2013109.","journal-title":"Europace"},{"issue":"2","key":"1030_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","volume":"15","author":"Ray E. Hershberger","year":"2009","unstructured":"Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MRG, Towbin JA, Heart Failure Society of America. Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America practice guideline. J Card Fail 2009:15:83\u201397.","journal-title":"Journal of Cardiac Failure"},{"key":"1030_CR45","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/eurjhf\/hfq093","volume":"12","author":"M Moretti","year":"2010","unstructured":"Moretti M, Merlo M, Barbati G, Di Lenarda A, Brun F, Pinamonti B, et al. Prognostic impact of familial screening in dilated cardiomyopathy. Eur J Heart Fail. 2010;12:922\u20137.","journal-title":"Eur J Heart Fail"},{"key":"1030_CR46","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1111\/j.1540-8159.2008.00956.x","volume":"31","author":"KY Spaendonck-Zwarts van","year":"2008","unstructured":"van Spaendonck-Zwarts KY, van den Berg MP, van Tintelen JP. DNA analysis in inherited cardiomyopathies: current status and clinical relevance. Pacing Clin Electrophysiol. 2008;31:S46\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1030_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/CIRCGENETICS.110.958918","volume":"4","author":"D Fatkin","year":"2011","unstructured":"Fatkin D, Yeoh T, Hayward CS, Benson V, Sheu A, Richmond Z, et al. Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy. Circ Cardiovasc Genet. 2011;4:342\u20138.","journal-title":"Circ Cardiovasc Genet"},{"key":"1030_CR48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","volume":"39","author":"NE Hasselberg","year":"2018","unstructured":"\u2022 Hasselberg NE, Haland TF, Saberniak J, Brekke PH, Berge KE, Leren TP, et al. Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 2018;39:853\u201360. This article provides the prevalence and cardiac penetrance of lamin mutation in a large norwegian DCM cohort.","journal-title":"Eur Heart J"},{"key":"1030_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/CIRCGENETICS.112.962761","volume":"5","author":"NK Lakdawala","year":"2012","unstructured":"Lakdawala NK, Thune JJ, Colan SD, Cirino AL, Farrohi F, Rivero J, et al. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy. Circ Cardiovasc Genet. 2012;5:503\u201310.","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"1030_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.117.002004","volume":"10","author":"G Sinagra","year":"2017","unstructured":"Sinagra G, Ferro MD, Merlo M. Lamin A\/C cardiomyopathy. Circ Cardiovasc Genet. 2017;10(6):e002004. https:\/\/doi.org\/10.1161\/CIRCGENETICS.117.002004 .","journal-title":"Circ Cardiovasc Genet"},{"issue":"36","key":"1030_CR51","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"2015","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;2015(36):2793\u2013867.","journal-title":"Eur Heart J"},{"key":"1030_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ng815","volume":"30","author":"B Gerull","year":"2002","unstructured":"Gerull B, Gramlich M, Atherton J, McNabb M, Trombit\u00e1s K, Sasse-Klaassen S, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet. 2002;30:201\u20134.","journal-title":"Nat Genet"},{"key":"1030_CR53","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","volume":"39","author":"JAJ Verdonschot","year":"2018","unstructured":"\u2022 Verdonschot JAJ, Hazebroek MR, Derks KWJ, et al. Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias. Eur Heart J. 2018;39:864\u201373. This article shows the structural and metabolic alterations that carachterize heart with titin truncating mutations.","journal-title":"Eur Heart J"},{"key":"1030_CR54","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1016\/j.jacc.2017.08.063","volume":"70","author":"U Tayal","year":"2017","unstructured":"Tayal U, Newsome S, Buchan R, Whiffin N, Halliday B, Lota A, et al. Phenotype and clinical outcomes of titin cardiomyopathy. J Am Coll Cardiol. 2017;70:2264\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1030_CR55","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002645","volume":"4","author":"RL Begay","year":"2015","unstructured":"Begay RL, Graw S, Sinagra G, Merlo M, Slavov D, Gowan K, et al. Role of titin missense variants in dilated cardiomyopathy. J Am Heart Assoc. 2015;4(11):e002645. https:\/\/doi.org\/10.1161\/JAHA.115.002645 .","journal-title":"J Am Heart Assoc"},{"key":"1030_CR56","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/hrt.2011.227967","volume":"97","author":"P Garcia-Pavia","year":"2011","unstructured":"Garcia-Pavia P, Syrris P, Salas C, Evans A, Mirelis JG, Cobo-Marcos M, et al. Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study. Heart. 2011;97:1744\u201352.","journal-title":"Heart"},{"key":"1030_CR57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ceb.2015.01.004","volume":"32","author":"Y Capetanaki","year":"2015","unstructured":"Capetanaki Y, Papathanasiou S, Diokmetzidou A, Vatsellas G, Tsikitis M. Desmin related disease: a matter of cell survival failure. Curr Opin Cell Biol. 2015;32:113\u201320.","journal-title":"Curr Opin Cell Biol"},{"key":"1030_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ejheart.2005.11.003","volume":"8","author":"E Arbustini","year":"2006","unstructured":"Arbustini E, Pasotti M, Pilotto A, Pellegrini C, Grasso M, Previtali S, et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail. 2006;8:477\u201383.","journal-title":"Eur J Heart Fail"},{"key":"1030_CR59","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1081578","volume":"299","author":"JP Schmitt","year":"2003","unstructured":"Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 2003;299:1410\u20133.","journal-title":"Science"},{"key":"1030_CR60","doi-asserted-by":"publisher","first-page":"22235","DOI":"10.1038\/srep22235","volume":"6","author":"M Fish","year":"2016","unstructured":"Fish M, Shaboodien G, Kraus S, Sliwa K, Seidman CE, Burke MA, et al. Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies. Sci Rep. 2016;6:22235.","journal-title":"Sci Rep"},{"key":"1030_CR61","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1073\/pnas.0510519103","volume":"103","author":"K Haghighi","year":"2006","unstructured":"Haghighi K, Kolokathis F, Gramolini AO, Waggoner JR, Pater L, Lynch RA, et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci. 2006;103:1388\u201393.","journal-title":"Proc Natl Acad Sci"},{"key":"1030_CR62","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA Zwaag van der","year":"2012","unstructured":"van der Zwaag PA, van Rijsingen IAW, Asimaki A, Jongbloed JDH, van Veldhuisen DJ, Wiesfeld ACP, et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail. 2012;14:1199\u2013207.","journal-title":"Eur J Heart Fail"},{"key":"1030_CR63","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","volume":"57","author":"WP McNair","year":"2011","unstructured":"McNair WP, Sinagra G, Taylor MRG, di Lenarda A, Ferguson DA, Salcedo EE, et al. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol. 2011;57:2160\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1030_CR64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1752-8062.2010.00198.x","volume":"3","author":"D Li","year":"2010","unstructured":"Li D, Morales A, Gonzalez-Quintana J, Norton N, Siegfried JD, Hofmeyer M, et al. Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci. 2010;3(3):90\u20137. https:\/\/doi.org\/10.1111\/j.1752-8062.2010.00198.x .","journal-title":"Clin Transl Sci"},{"issue":"5","key":"1030_CR65","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nm.2693","volume":"18","author":"W Guo","year":"2012","unstructured":"Guo W, Schafer S, Greaser ML, Radke MH, Liss M, Govindarajan T, et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med. 2012;18(5):766\u201373. https:\/\/doi.org\/10.1038\/nm.2693 .","journal-title":"Nat Med"},{"key":"1030_CR66","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/01.wnl.0000261254.87181.80","volume":"69","author":"S Benedetti","year":"2007","unstructured":"Benedetti S, Menditto I, Degano M, Rodolico C, Merlini L, D'Amico A, et al. Phenotypic clustering of lamin A\/C mutations in neuromuscular patients. Neurology. 2007;69:1285\u201392.","journal-title":"Neurology"},{"key":"1030_CR67","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0140-6736(03)14069-X","volume":"362","author":"L Chen","year":"2003","unstructured":"Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y, et al. LMNA mutations in atypical Werner\u2019s syndrome. Lancet. 2003;362:440\u20135.","journal-title":"Lancet"},{"key":"1030_CR68","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","volume":"59","author":"IAW Rijsingen Van","year":"2012","unstructured":"Van Rijsingen IAW, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study. J Am Coll Cardiol. 2012;59:493\u2013500.","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR69","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/eurjhf\/hfs191","volume":"15","author":"IAW Rijsingen van","year":"2013","unstructured":"van Rijsingen IAW, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, et al. Gender-specific differences in major cardiac events and mortality in lamin A\/C mutation carriers. Eur J Heart Fail. 2013;15:376\u201384.","journal-title":"Eur J Heart Fail"},{"key":"1030_CR70","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","volume":"52","author":"M Pasotti","year":"2008","unstructured":"Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"1030_CR71","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2016.08.079","volume":"68","author":"MA Burke","year":"2016","unstructured":"Burke MA, Cook SA, Seidman JG, Seidman CE. Clinical and mechanistic insights into the genetics of cardiomyopathy. J Am Coll Cardiol. 2016;68(25):2871\u201386. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.079 .","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1086\/431959","volume":"77","author":"M Vorgerd","year":"2005","unstructured":"Vorgerd M, van der Ven PFM, Bruchertseifer V, L\u00f6we T, Kley RA, Schr\u00f6der R, et al. A mutation in the dimerization domain of filamin C causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet. 2005;77:297\u2013304.","journal-title":"Am J Hum Genet"},{"key":"1030_CR73","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1093\/brain\/awm271","volume":"130","author":"RA Kley","year":"2007","unstructured":"Kley RA, Hellenbroich Y, van der Ven PFM, Furst DO, Huebner A, Bruchertseifer V, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain. 2007;130:3250\u201364.","journal-title":"Brain"},{"key":"1030_CR74","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1038\/ncomms6326","volume":"5","author":"R Vald\u00e9s-Mas","year":"2014","unstructured":"Vald\u00e9s-Mas R, Guti\u00e9rrez-Fern\u00e1ndez A, G\u00f3mez J, Coto E, Astudillo A, Puente DA, et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy. Nat Commun. 2014;5:5326. https:\/\/doi.org\/10.1038\/ncomms6326 .","journal-title":"Nat Commun"},{"issue":"3","key":"1030_CR75","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/humu.22942","volume":"37","author":"A Brodehl","year":"2016","unstructured":"Brodehl A, Ferrier RA, Hamilton SJ, Greenway SC, Brundler MA, Yu W, et al. Mutations in FLNC are associated with familial restrictive cardiomyopathy. Hum Mutat. 2016;37(3):269\u201379. https:\/\/doi.org\/10.1002\/humu.22942 .","journal-title":"Hum Mutat"},{"key":"1030_CR76","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/35052082","volume":"2","author":"TP Stossel","year":"2001","unstructured":"Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001;2:138\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1030_CR77","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2009.12.001","volume":"20","author":"A-X Zhou","year":"2010","unstructured":"Zhou A-X, Hartwig JH, Aky\u00fcrek LM. Filamins in cell signaling, transcription and organ development. Trends Cell Biol. 2010;20:113\u201323.","journal-title":"Trends Cell Biol"},{"key":"1030_CR78","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","volume":"121","author":"D Corrado","year":"2017","unstructured":"Corrado D, Basso C, Judge DP. Arrhythmogenic cardiomyopathy. Circ Res. 2017;121:784\u2013802.","journal-title":"Circ Res"},{"key":"1030_CR79","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/FJC.0000000000000007","volume":"63","author":"MM LeWinter","year":"2014","unstructured":"LeWinter MM, Granzier HL. Cardiac titin and heart disease. J Cardiovasc Pharmacol. 2014;63:207\u201312.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1030_CR80","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCGENETICS.116.001431","volume":"9","author":"R Hastings","year":"2016","unstructured":"Hastings R, De Villiers CP, Hooper C, et al. Combination of whole genome sequencing, linkage, and functional studies implicates a missense mutation in titin as a cause of autosomal dominant cardiomyopathy with features of left ventricular noncompaction. Circ Cardiovasc Genet. 2016;9:426\u201335.","journal-title":"Circ Cardiovasc Genet"},{"key":"1030_CR81","first-page":"367","volume":"53","author":"I Sarantitis","year":"2012","unstructured":"Sarantitis I, Papanastasopoulos P, Manousi M, Baikoussis NG, Apostolakis E. The cytoskeleton of the cardiac muscle cell. Hell J Cardiol. 2012;53:367\u201379.","journal-title":"Hell J Cardiol"},{"key":"1030_CR82","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.CIR.100.5.461","volume":"100","author":"D Li","year":"1999","unstructured":"Li D, Tapscoft T, Gonzalez O, Burch PE, Qui\u00f1ones MA, Zoghbi WA, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation. 1999;100:461\u20134. https:\/\/doi.org\/10.1161\/01.CIR.100.5.461 .","journal-title":"Circulation"},{"key":"1030_CR83","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvv127","volume":"107","author":"G-S Liu","year":"2015","unstructured":"Liu G-S, Morales A, Vafiadaki E, Lam CK, Cai W-F, Haghighi K, et al. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res. 2015;107:164\u201374.","journal-title":"Cardiovasc Res"},{"key":"1030_CR84","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/his.12963","volume":"69","author":"WP Rijdt te","year":"2016","unstructured":"te Rijdt WP, van Tintelen JP, Vink A, van der Wal AC, de Boer RA, van den Berg MP, et al. Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation. Histopathology. 2016;69:542\u201350.","journal-title":"Histopathology"},{"issue":"7","key":"1030_CR85","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jacc.2006.07.016","volume":"48","author":"MM Dewitt","year":"2006","unstructured":"Dewitt MM, Macleod HM, Soliven B, Mcnally EM, Chicago I. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(7):1396\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2006.07.016 .","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12881-015-0167-0","volume":"16","author":"GT Truszkowska","year":"2015","unstructured":"Truszkowska GT, Bili\u0144ska ZT, Kosi\u0144ska J, \u015aleszycka J, Rydzanicz M, Sobieszcza\u0144ska-Ma\u0142ek M, et al. A study in polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations. BMC Med Genet. 2015;16:21. https:\/\/doi.org\/10.1186\/s12881-015-0167-0 .","journal-title":"BMC Med Genet"},{"key":"1030_CR87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/0975-3583.64437","volume":"1","author":"P Liang","year":"2010","unstructured":"Liang P, Liu W, Li C, Tao W, Li L, Hu D. Genetic analysis of Brugada syndrome and congenital long-QT syndrome type 3 in the Chinese. J Cardiovasc Dis Res. 2010;1:69\u201374.","journal-title":"J Cardiovasc Dis Res"},{"issue":"19","key":"1030_CR88","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.jacc.2016.07.779","volume":"68","author":"P Liang","year":"2016","unstructured":"Liang P, Sallam K, Wu H, Li Y, Itzhaki I, Garg P, et al. Patient-specific and genome-edited induced pluripotent stem cell\u2013derived cardiomyocytes elucidate single-cell phenotype of Brugada syndrome. J Am Coll Cardiol. 2016;68(19):2086\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2016.07.779 .","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1030_CR89","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1172\/JCI74523","volume":"124","author":"H Maatz","year":"2014","unstructured":"Maatz H, Jens M, Liss M, Schafer S, Heinig M, Kirchner M, et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest. 2014;124(8):3419\u201330. https:\/\/doi.org\/10.1172\/JCI74523 .","journal-title":"J Clin Invest"},{"key":"1030_CR90","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","volume":"35","author":"JN Cohn","year":"2000","unstructured":"Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 2000;35:569\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"1030_CR91","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2459\/JCM.0b013e32832bba35","volume":"10","author":"A Aleksova","year":"2009","unstructured":"Aleksova A, Sabbadini G, Merlo M, Pinamonti B, Barbati G, Zecchin M, et al. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure\u2014a subgroup analysis from the Trieste Cardiomyopathy Registry. J Cardiovasc Med. 2009;10:699\u2013705.","journal-title":"J Cardiovasc Med"},{"key":"1030_CR92","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijcha.2018.02.005","volume":"18","author":"M Merlo","year":"2018","unstructured":"Merlo M, Caiffa T, Gobbo M, Adamo L, Sinagra G. Reverse remodeling in dilated cardiomyopathy: insights and future perspectives. IJC Hear Vasc. 2018;18:52\u20137.","journal-title":"IJC Hear Vasc"},{"key":"1030_CR93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ejhf.16","volume":"16","author":"M Merlo","year":"2014","unstructured":"Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30\u2009years. Eur J Heart Fail. 2014;16:317\u201324.","journal-title":"Eur J Heart Fail"},{"key":"1030_CR94","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s000590050003","volume":"25","author":"NE Bowles","year":"2000","unstructured":"Bowles NE, Bowles KR, Towbin JA. The "final common pathway" hypothesis and inherited cardiovascular disease. Herz. 2000;25:168\u201375.","journal-title":"Herz"},{"key":"1030_CR95","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.jacc.2010.11.061","volume":"57","author":"JA Towbin","year":"2011","unstructured":"Towbin JA, Lorts A, Cincinnati O. Arrhythmias and dilated cardiomyopathy common pathogenetic pathways?*. J Am Coll Cardiol. 2011;57:2169\u201371.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-018-1030-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-1030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-1030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T03:32:30Z","timestamp":1661743950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-018-1030-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":95,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1007\/s11886-018-1030-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"13 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Alessia Paldino, Giulia De Angelis, Marco Merlo, Marta Gigli, Matteo Dal Ferro, Giovanni Maria Severini, Luisa Mestroni and Gianfranco Sinagra declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"83"}}